Literature DB >> 19252792

Epilepsia partialis continua successfully treated with levetiracetam.

Claus G Haase, Benjamin Hopmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19252792     DOI: 10.1007/s00415-009-5043-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  6 in total

1.  Epilepsia partialis continua: clinical and electrophysiological features of adult patients.

Authors:  G Gurer; S Saygi; A Ciger
Journal:  Clin Electroencephalogr       Date:  2001-01

2.  A patient with a 44-year history of epilepsia partialis continua caused by a perirolandic cortical dysplasia.

Authors:  Karl O Nakken; Andrés Server; Hrisimir Kostov; Monika Haakonsen
Journal:  Epilepsy Behav       Date:  2005-02       Impact factor: 2.937

3.  Epilepsia Partialis Continua over last 14 years: experience from a tertiary care center from south India.

Authors:  S Sinha; P Satishchandra
Journal:  Epilepsy Res       Date:  2007-02-09       Impact factor: 3.045

4.  Clinical and physiological features of epilepsia partialis continua. Cases ascertained in the UK.

Authors:  O C Cockerell; J Rothwell; P D Thompson; C D Marsden; S D Shorvon
Journal:  Brain       Date:  1996-04       Impact factor: 13.501

5.  Chronic isolated hemifacial spasm as a manifestation of epilepsia partialis continua.

Authors:  Alberto J Espay; Vincent J Schmithorst; Jerzy P Szaflarski
Journal:  Epilepsy Behav       Date:  2007-10-24       Impact factor: 2.937

6.  Epilepsia partialis continua with dystonic hand movement in a patient with a malformation of cortical development.

Authors:  Julie Zyss; Jing Xie-Brustolin; Philippe Ryvlin; Stéphane Peysson; Albert Beschet; Dominique Sappey-Marinier; Marc Hermier; Stéphane Thobois
Journal:  Mov Disord       Date:  2007-09-15       Impact factor: 10.338

  6 in total
  1 in total

1.  Levetiracetam induced encephalopathy in a patient with normal renal function: An unusual clinical encounter.

Authors:  Rajesh Verma; Rakesh Lalla; Tushar B Patil
Journal:  Ann Indian Acad Neurol       Date:  2013-10       Impact factor: 1.383

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.